Designing light-sensitive proteins to study heart cell behavior
Optogenetic protein design for hypertrophic signaling pathways
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10853062
This study is exploring new ways to use light to control proteins in heart cells, helping researchers learn how these cells work and how they might be involved in heart issues like thickening and scarring, which could lead to better treatments for heart conditions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10853062 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative light-responsive proteins to better understand how heart cells regulate their behavior and maintain homeostasis. By using a technique called optogenetics, the researchers aim to create proteins that can be activated by light, allowing them to investigate the biochemical pathways involved in heart conditions like hypertrophy and fibrosis. The study will involve engineering these proteins, mapping their signaling pathways, and examining how they influence heart cell responses. This approach could provide new insights into heart diseases and potential treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cardiovascular diseases, particularly those experiencing hypertrophy or fibrosis of the heart.
Not a fit: Patients with non-cardiovascular conditions or those not experiencing heart-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for heart diseases by providing a deeper understanding of the cellular mechanisms involved in heart function.
How similar studies have performed: Other research has shown promise in using optogenetic approaches in neuroscience, but this specific application in cardiovascular research is relatively novel.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HAAR, LAUREN L — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: HAAR, LAUREN L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.